Clinical application research of balloon-occluded transcatheter arterial chemoembolization for liver cancer
10.3969/j.issn.1008-794X.2024.09.001
- VernacularTitle:球囊封堵TACE治疗肝癌的临床应用研究
- Author:
Tongguo SI
1
Author Information
1. 300060 天津 天津医科大学肿瘤医院(天津市肿瘤医院空港医院,国家恶性肿瘤临床医学研究中心,天津市肿瘤防治重点实验室,天津市恶性肿瘤临床医学研究中心)
- Keywords:
balloon occlusion;
chemoembolization;
liver cancer
- From:
Journal of Interventional Radiology
2024;33(9):935-938
- CountryChina
- Language:Chinese
-
Abstract:
With the continuous development of relevant materials,balloon-occluded transcatheter arterial chemoembolization(TACE)has been gradually applied in clinical practice and has become a clinical hot spot of attention in recent years.The results of preliminary studies indicate that balloon-occluded TACE technology can improve the local control rate and reduce the recurrence rate of lesion in some patients with hepatocellular carcinoma(HCC),and this therapeutic technology can be employed in patients who develop recurrence after receiving conventional TACE and in patients who are scheduled to receive preoperative bridging treatment,besides,it can also be adopted together with selective internal irradiation therapy(SIRT)and ablation therapy.However,how to determine the best suitable patients for the technique,whether this technology will increase liver function damage,whether there are special complications,etc.,are all the issues that need to be paid attention to in clinical application.The technical conditions of its clinical application,prognostic factors and how to combine it with other interventional techniques need to be further discussed.
